COST ANALYSIS OF PATIENTS WITH SQUAMOUS CELL CERVICAL CANCER STAGE IIB-IIIB WITH PACLITAXEL CISPLATIN CHEMOTHERAPY FROM THE SOCIETAL PERSPECTIVE. Journal Pharmaceutical Science and Application, v. 5, n. 1, p. 34–44, 1 Jun.2023.